David Rivera
Gastroenterology · Bayamon, PRNPI 1851334262
Payments from drug & device makers
Across 89 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$229
- E.r. Squibb & Sons, L.L.C.$199
- Gilead$117
- Genentech USA, Inc.$94
- Eli Lilly Export S.A. Puerto Rico Branch$87
- plus $322 from 8 others
What the payments were for
- Food & beverage$2,097100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $1,049 |
| Johnson & Johnson | 10 | $229 |
| E.r. Squibb & Sons, L.L.C. | 10 | $199 |
| Gilead | 6 | $117 |
| Genentech USA, Inc. | 1 | $94 |
| Eli Lilly Export S.A. Puerto Rico Branch | 4 | $87 |
| Ferring Pharmaceuticals Inc. | 4 | $76 |
| Olympus Latin America, Inc. | 1 | $71 |
| Intercept Pharmaceuticals, Inc. | 2 | $51 |
| Exact Sciences | 2 | $47 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Merck | 1 | $19 |
| Amgen | 1 | $17 |
| PBG Puerto Rico LLC | 1 | $14 |
How this compares
$2,097 in reported general payments places this provider in the 55th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $86,828 |
| Esomeprazole Magnesium | 588 | $11,319 |
| Mesalamine | 34 | $9,231 |
| Mesalamine DrMesalamine | 24 | $8,883 |
| Famotidine | 851 | $6,380 |
| SuprepSodium, Potassium,mag Sulfates | 53 | $6,251 |
| Sucralfate | 82 | $4,189 |
| Dexlansoprazole DrDexlansoprazole | 19 | $4,123 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 51 | $3,960 |
| Pantoprazole Sodium | 265 | $2,101 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 12 | $2,009 |
| Lansoprazole | 141 | $1,798 |
| Lubiprostone | 21 | $1,469 |
| Hydrocortisone | 43 | $1,423 |
| Procto-Med HcHydrocortisone | 31 | $1,042 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bayamon
- Roberto Osorio ManotasBayamon$25K
- Joham Senior MarinoBayamon$18K
- Jorge Cortes RuizBayamon$15K
- Santiago Coste-SibiliaBayamon$11K
- Rafael SolisBayamon$8K
- Henry de Jesus-De la CruzBayamon$8K
- Marcia Cruz CorreaSan Juan$12.4M
- Jose Rivera-AcostaSan Juan$882K
- Esther TorresSan Juan$493K
- Ruben Lugo ZambranaGuayama$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.